{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T14:19:43Z","timestamp":1793110783798,"version":"4.5.0"},"publisher-location":"Singapore","reference-count":105,"publisher":"Springer Singapore","isbn-type":[{"value":"9789811525162","type":"print"},{"value":"9789811525179","type":"electronic"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/978-981-15-2517-9_2","type":"book-chapter","created":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T13:18:26Z","timestamp":1585919906000},"page":"37-73","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":83,"title":["Evidence in Guidelines for Treatment of Coronary Artery Disease"],"prefix":"10.1007","author":[{"given":"Sida","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinqing","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,26]]},"reference":[{"key":"2_CR1","unstructured":"ACCORD Study Group (2010) Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 362(17): 1575"},{"key":"2_CR2","unstructured":"American College of Emergency P, Society for Cardiovascular A, Interventions et al (2013) ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 61(4): e78\u2013140"},{"key":"2_CR3","doi-asserted-by":"crossref","unstructured":"American Heart Association Nutrition C, Lichtenstein AH, Appel LJ, et al (2006) Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation 114(1): 82\u201396","DOI":"10.1161\/CIRCULATIONAHA.106.176158"},{"issue":"24","key":"2_CR4","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1016\/j.jacc.2014.09.017","volume":"64","author":"EA Amsterdam","year":"2014","unstructured":"Amsterdam EA, Wenger NK, Brindis RG et al (2014) 2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 64(24):e139\u2013e228","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"2_CR5","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1016\/0735-1097(95)00042-3","volume":"25","author":"D Ardissino","year":"1995","unstructured":"Ardissino D et al (1995) Selection of medical treatment in stable angina pectoris: results of the International Multicenter Angina Exercise (IMAGE) Study. J Am Coll Cardiol 25(7):1516\u20131521","journal-title":"J Am Coll Cardiol"},{"key":"2_CR6","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.ahj.2016.05.012","volume":"178","author":"LV Armaganijan","year":"2016","unstructured":"Armaganijan LV, Alexander KP, Huang Z et al (2016) Effect of age on efficacy and safety of vorapaxar in patients with non-ST-segment elevation acute coronary syndrome: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial. Am Heart J 178:176\u2013184","journal-title":"Am Heart J"},{"issue":"12","key":"2_CR7","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.acvd.2015.10.007","volume":"109","author":"V Auffret","year":"2016","unstructured":"Auffret V, Leurent G, Boulmier D et al (2016) Efficacy and safety of prehospital administration of unfractionated heparin, enoxaparin or bivalirudin in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Insights from the ORBI registry. Arch Cardiovasc Dis 109(12):696\u2013707","journal-title":"Arch Cardiovasc Dis"},{"key":"2_CR8","unstructured":"Baigent C et al (2010) Cholesterol Treatment Trialists\u2019 (CTT) Collaborators. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials. Lancet. 376(9753): 1670\u20131681"},{"issue":"5","key":"2_CR9","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.amjcard.2015.05.058","volume":"116","author":"C Bavishi","year":"2015","unstructured":"Bavishi C, Panwar S, Messerli FH, Bangalore S (2015) Meta-analysis of comparison of the newer Oral P2Y12 Inhibitors (Prasugrel or Ticagrelor) to Clopidogrel in patients with non-ST-elevation acute coronary syndrome. Am J Cardiol 116(5):809\u2013817","journal-title":"Am J Cardiol"},{"issue":"1","key":"2_CR10","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.amjmed.2007.10.002","volume":"121","author":"JS Berger","year":"2008","unstructured":"Berger JS, Brown DL, Becker RC (2008) Low-dose aspirin in patients with stable cardiovascular disease: a meta-analysis. Am J Med 121(1):43\u201349","journal-title":"Am J Med"},{"issue":"6","key":"2_CR11","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.3945\/ajcn.113.066381","volume":"98","author":"SN Bhupathiraju","year":"2013","unstructured":"Bhupathiraju SN, Wedick NM, Pan A et al (2013) Quantity and variety in fruit and vegetable intake and risk of coronary heart disease. Am J Clin Nutr 98(6):1514\u20131523","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"2_CR12","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/S0140-6736(03)14190-6","volume":"55","author":"JA Blumenthal","year":"2003","unstructured":"Blumenthal JA et al (2003) Depression as a risk factor for mortality after coronary artery bypass surgery. Lancet 55(2):604","journal-title":"Lancet"},{"issue":"6","key":"2_CR13","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.ahj.2006.07.022","volume":"152","author":"S Brener","year":"2006","unstructured":"Brener S et al (2006) Antihypertensive therapy and regression of coronary artery disease: insights from the Comparison of Amlodipine versus Enalapril to Limit Occurrences of Thrombosis (CAMELOT) and Norvasc for Regression of Manifest Atherosclerotic Lesions by Intravascular. Am Heart J 152(6):1059\u20131063","journal-title":"Am Heart J"},{"issue":"4","key":"2_CR14","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1097\/01.PSY.0000077509.39465.79","volume":"65","author":"MM Burg","year":"2003","unstructured":"Burg MM, Benedetto MC, Soufer R (2003) Depressive symptoms and mortality two years after coronary artery bypass graft surgery (CABG) in men. Psychosom Med 65(4):508","journal-title":"Psychosom Med"},{"key":"2_CR15","unstructured":"Camafort M et al (2011) Glucose control and outcome in patients with stable diabetes and previous coronary, cerebrovascular or peripheral artery disease. Findings from the FRENA registry. Diabet Med 28(1): 73\u201380"},{"key":"2_CR16","doi-asserted-by":"crossref","unstructured":"Chaitman BR et al (2004) Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina. J Am Coll Card 43(8): 1375\u20131382","DOI":"10.1016\/j.jacc.2003.11.045"},{"issue":"1","key":"2_CR17","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/00045391-200501000-00006","volume":"12","author":"EI Chazov","year":"2005","unstructured":"Chazov EI et al (2005) Trimetazidine in Angina Combination Therapy\u2013the TACT study: trimetazidine versus conventional treatment in patients with stable angina pectoris in a randomized, placebo-controlled, multicenter study. Am J Ther 12(1):35","journal-title":"Am J Ther"},{"issue":"4","key":"2_CR18","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.physbeh.2013.05.024","volume":"118","author":"H Chen","year":"2013","unstructured":"Chen H et al (2013) Relationship of depression, stress and endothelial function in stable angina patients. Physiol Behav 118(4):152\u2013158","journal-title":"Physiol Behav"},{"issue":"6","key":"2_CR19","doi-asserted-by":"publisher","first-page":"e97862","DOI":"10.1371\/journal.pone.0097862","volume":"9","author":"V Chetboul","year":"2014","unstructured":"Chetboul V, Reynolds BS, Trehiou-Sechi E et al (2014) Cardiovascular effects of dietary salt intake in aged healthy cats: a 2-year prospective randomized, blinded, and controlled study. PLoS ONE 9(6):e97862","journal-title":"PLoS ONE"},{"issue":"6","key":"2_CR20","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1161\/CIRCULATIONAHA.109.891523","volume":"121","author":"CK Chow","year":"2010","unstructured":"Chow CK et al (2010) Association of diet, exercise, and smoking modification with risk of early cardiovascular events after acute coronary syndromes. Circulation 121(6):750","journal-title":"Circulation"},{"issue":"14","key":"2_CR21","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1161\/CIRCULATIONAHA.114.009985","volume":"130","author":"DJ Cohen","year":"2014","unstructured":"Cohen DJ et al (2014) Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial. Circulation 130(14):1146\u20131157","journal-title":"Circulation"},{"issue":"1","key":"2_CR22","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1001\/jama.290.1.86","volume":"290","author":"JA Critchley","year":"2003","unstructured":"Critchley JA, Capewell S (2003) Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA J Am Med Assoc 290(1):86\u201397","journal-title":"JAMA J Am Med Assoc"},{"issue":"3","key":"2_CR23","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.ijcard.2012.03.094","volume":"167","author":"GW Dalmeijer","year":"2013","unstructured":"Dalmeijer GW, Struijk EA, van der Schouw YT et al (2013) Dairy intake and coronary heart disease or stroke\u2014a population-based cohort study. Int J Cardiol 167(3):925\u2013929","journal-title":"Int J Cardiol"},{"issue":"11","key":"2_CR24","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1056\/NEJMoa1205361","volume":"367","author":"B Bruyne De","year":"2012","unstructured":"De Bruyne B et al (2012) Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med 367(11):991\u20131001","journal-title":"N Engl J Med"},{"issue":"1","key":"2_CR25","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ahj.2005.09.024","volume":"152","author":"DB Diercks","year":"2006","unstructured":"Diercks DB et al (2006) The obesity paradox in non-ST-segment elevation acute coronary syndromes: results from the can rapid risk stratification of unstable angina patients suppress adverse outcomes with early implementation of the American College of Cardiology\/American Heart Association guidelines quality improvement initiative. Am Heart J 152(1):140\u2013148","journal-title":"Am Heart J"},{"issue":"7","key":"2_CR26","doi-asserted-by":"publisher","first-page":"e002258","DOI":"10.1161\/CIRCINTERVENTIONS.114.002258","volume":"8","author":"IY Elgendy","year":"2015","unstructured":"Elgendy IY, Huo T, Bhatt DL, Bavry AA (2015) Is aspiration thrombectomy beneficial in patients undergoing primary percutaneous coronary intervention? Meta-analysis of randomized trials. Circ Cardiovasc Interv 8(7):e002258","journal-title":"Circ Cardiovasc Interv"},{"issue":"1","key":"2_CR27","doi-asserted-by":"publisher","first-page":"e000258","DOI":"10.1136\/openhrt-2015-000258","volume":"2","author":"M Farag","year":"2015","unstructured":"Farag M, Gorog DA, Prasad A, Srinivasan M (2015) Bivalirudin versus unfractionated heparin: a meta-analysis of patients receiving percutaneous coronary intervention for acute coronary syndromes. Open Heart 2(1):e000258","journal-title":"Open Heart"},{"issue":"25","key":"2_CR28","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1056\/NEJMoa1211585","volume":"367","author":"ME Farkouh","year":"2012","unstructured":"Farkouh ME et al (2012) Strategies for multivessel revascularization in patients with diabetes. N Engl J Med 367(25):2375\u20132384","journal-title":"N Engl J Med"},{"issue":"24","key":"2_CR29","first-page":"2564","volume":"60","author":"SD Fihn","year":"2012","unstructured":"Fihn SD et al (2012) 2012 ACCF\/AHA\/ACP\/AATS\/PCNA\/SCAI\/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease A Report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines, and the A. Circulation 60(24):2564\u20132603","journal-title":"Circulation"},{"key":"2_CR30","unstructured":"Fox KM et al (1996) The Total Ischaemic Burden European Trial (TIBET). Effects of atenolol, nifedipine SR and their combination on the exercise test and the total ischaemic burden in 608 patients with stable angina. The TIBET Study Group. Eur Heart J 17(1): 96\u2013103"},{"issue":"9386","key":"2_CR31","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/S0140-6736(03)14286-9","volume":"362","author":"KM Fox","year":"2003","unstructured":"Fox KM (2003) Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet 362(9386):782\u2013788","journal-title":"Lancet"},{"issue":"9641","key":"2_CR32","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/S0140-6736(08)61170-8","volume":"372","author":"K Fox","year":"2008","unstructured":"Fox K et al (2008) Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial. Lancet 372(9641):807\u2013816","journal-title":"Lancet"},{"issue":"6","key":"2_CR33","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1001\/archpsyc.60.6.627","volume":"60","author":"N Frasuresmith","year":"2003","unstructured":"Frasuresmith N, Lesp\u00e9rance F (2003) Depression and other psychological risks following myocardial infarction. Arch Gen Psychiatry 60(6):627\u2013636","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"2_CR34","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1001\/archgenpsychiatry.2007.4","volume":"65","author":"N Frasuresmith","year":"2008","unstructured":"Frasuresmith N, Lesp\u00e9rance F (2008) Depression and anxiety as predictors of 2-year cardiac events in patients with stable coronary artery disease. Arch Gen Psychiatry 65(1):62","journal-title":"Arch Gen Psychiatry"},{"key":"2_CR35","unstructured":"Frasuresmith N, Lesp\u00e9rance F, Talajic M (1993) Depression following myocardial infarction. Impact on 6-month survival. JAMA J Am Med Assoc 270(15): 1819"},{"key":"2_CR36","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ijcard.2015.01.077","volume":"183","author":"Y Gan","year":"2015","unstructured":"Gan Y, Tong X, Li L et al (2015) Consumption of fruit and vegetable and risk of coronary heart disease: a meta-analysis of prospective cohort studies. Int J Cardiol 183:129\u2013137","journal-title":"Int J Cardiol"},{"issue":"2","key":"2_CR37","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1002\/ccd.26232","volume":"88","author":"T Geisler","year":"2016","unstructured":"Geisler T, Droppa M, Gawaz M et al (2016) Impact of anticoagulation regimen prior to revascularization in patients with non-ST-segment elevation acute coronary syndromes: The ACUITY trial. Catheter Cardiovasc Interv 88(2):174\u2013181","journal-title":"Catheter Cardiovasc Interv"},{"issue":"1","key":"2_CR38","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/j.1755-5922.2010.00180.x","volume":"29","author":"M Glover","year":"2011","unstructured":"Glover M, Zuber AM, O\u2019Shaughnessy KM (2011) Hypertension, dietary salt intake, and the role of the thiazide-sensitive sodium chloride transporter NCCT. Cardiovasc Ther 29(1):68\u201376","journal-title":"Cardiovasc Ther"},{"issue":"11","key":"2_CR39","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1002\/pds.3678","volume":"23","author":"DJ Graham","year":"2014","unstructured":"Graham DJ et al (2014) Cardiovascular and mortality risks in older Medicare patients treated with varenicline or bupropion for smoking cessation: an observational cohort study. Pharmacoepidemiol Drug Saf 23(11):1205\u20131212","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"12","key":"2_CR40","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1016\/j.cjca.2013.09.014","volume":"29","author":"SM Grandi","year":"2013","unstructured":"Grandi SM, Shimony A, Eisenberg MJ (2013) Bupropion for smoking cessation in patients hospitalized with cardiovascular disease: a systematic review and meta-analysis of randomized controlled trials. Can J Cardiol 29(12):1704\u20131711","journal-title":"Can J Cardiol"},{"issue":"4","key":"2_CR41","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s10557-016-6677-y","volume":"30","author":"G Guarini","year":"2016","unstructured":"Guarini G et al (2016) Pharmacological agents targeting myocardial metabolism for the management of chronic stable angina: an update. Cardiovasc Drugs Ther 30(4):379\u2013391","journal-title":"Cardiovasc Drugs Ther"},{"key":"2_CR42","doi-asserted-by":"crossref","unstructured":"Gunton J, Hartshorne T, Langrish J, Chuang A, Chew D (2016) P2Y12 inhibitor pre-treatment in non-ST-elevation acute coronary syndrome: a decision-analytic model. J Clin Med 5(8)","DOI":"10.3390\/jcm5080072"},{"issue":"1","key":"2_CR43","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ehj.2003.10.018","volume":"25","author":"EP Gurfinkel","year":"2004","unstructured":"Gurfinkel EP et al (2004) Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) Study. Eur Heart J 25(1):25\u201331","journal-title":"Eur Heart J"},{"issue":"6","key":"2_CR44","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1007\/s11883-010-0136-1","volume":"12","author":"KA Harris","year":"2010","unstructured":"Harris KA, Kris-Etherton PM (2010) Effects of whole grains on coronary heart disease risk. Curr Atheroscler Rep 12(6):368\u2013376","journal-title":"Curr Atheroscler Rep"},{"issue":"5","key":"2_CR45","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1177\/1074248416640161","volume":"21","author":"JR Harris","year":"2016","unstructured":"Harris JR, Hale GM, Dasari TW, Schwier NC (2016) Pharmacotherapy of vasospastic angina. J Cardiovasc Pharmacol Ther 21(5):439\u2013451","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"2_CR46","doi-asserted-by":"crossref","unstructured":"Hermanson B et al (1988) Beneficial six-year outcome of smoking cessation in older men and women with coronary artery disease. Results from the CASS registry. N Engl J Med 319(21): 1365","DOI":"10.1056\/NEJM198811243192101"},{"issue":"10","key":"2_CR47","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1016\/j.jacc.2003.08.065","volume":"43","author":"W Hueb","year":"2004","unstructured":"Hueb W et al (2004) The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one-year results. J Am Coll Cardiol 43(10):1743\u20131751","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"2_CR48","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1161\/CIRCULATIONAHA.106.625475","volume":"115","author":"W Hueb","year":"2007","unstructured":"Hueb W et al (2007) Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation 115(9):1082\u20131089","journal-title":"Circulation"},{"issue":"10","key":"2_CR49","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1161\/CIRCULATIONAHA.109.911669","volume":"122","author":"W Hueb","year":"2010","unstructured":"Hueb W et al (2010) Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation 122(10):949\u2013957","journal-title":"Circulation"},{"issue":"8","key":"2_CR50","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.amjcard.2015.01.530","volume":"115","author":"JS Jang","year":"2015","unstructured":"Jang JS, Jin HY, Seo JS et al (2015) Meta-analysis of multivessel versus culprit-only percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndrome and multivessel coronary disease. Am J Cardiol 115(8):1027\u20131032","journal-title":"Am J Cardiol"},{"issue":"4","key":"2_CR51","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1177\/2047487312462824","volume":"20","author":"V Janssen","year":"2012","unstructured":"Janssen V et al (2012) Lifestyle modification programmes for patients with coronary heart disease: a systematic review and meta-analysis of randomized controlled trials. Eur J Prev Cardiol 20(4):620\u2013640","journal-title":"Eur J Prev Cardiol"},{"issue":"10014","key":"2_CR52","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0140-6736(15)00448-1","volume":"387","author":"SS Jolly","year":"2016","unstructured":"Jolly SS, Cairns JA, Yusuf S et al (2016) Outcomes after thrombus aspiration for ST elevation myocardial infarction: 1-year follow-up of the prospective randomised TOTAL trial. Lancet 387(10014):127\u2013135","journal-title":"Lancet"},{"key":"2_CR53","doi-asserted-by":"crossref","unstructured":"Joseph AM, Norman SM, Ferry LH, Prochazka AV, Westman EC, Steele BG, Sherman SE, Cleveland M, Antonuccio DO, Hartman N, McGovern PG (1996) The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. NEJM N Engl J Med 335(24): 1792","DOI":"10.1056\/NEJM199612123352402"},{"issue":"9426","key":"2_CR54","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1016\/S0140-6736(04)16451-9","volume":"363","author":"S Julius","year":"2004","unstructured":"Julius S et al (2004) Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet 363(9426):2022\u20132031","journal-title":"Lancet"},{"key":"2_CR55","unstructured":"Juul-Moller S et al (1992) Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. The Swedish Angina Pectoris Aspirin Trial (SAPAT) Group. Lancet 340(8833): 1421\u20131425"},{"key":"2_CR56","unstructured":"Kolh P et al (2014) ESC\/EACTS guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of. Eur J Cardio-Thoracic Surg 72(4): 1253\u20131379"},{"issue":"20","key":"2_CR57","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1016\/j.jacc.2013.02.011","volume":"61","author":"M Kosiborod","year":"2013","unstructured":"Kosiborod M et al (2013) Evaluation of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina: results from the TERISA randomized clinical trial (Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina). J Am Coll Cardiol 61(20):2038\u20132045","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"2_CR58","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1161\/01.STR.31.11.2751","volume":"31","author":"RM Krauss","year":"2000","unstructured":"Krauss RM, Eckel RH, Howard B et al (2000) AHA dietary guidelines: revision 2000: a statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Stroke 31(11):2751\u20132766","journal-title":"Stroke"},{"issue":"15","key":"2_CR59","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1161\/CIRCULATIONAHA.113.004834","volume":"129","author":"M Lamberts","year":"2014","unstructured":"Lamberts M et al (2014) Antiplatelet therapy for stable coronary artery disease in atrial fibrillation patients taking an oral anticoagulant: a nationwide cohort study. Circulation 129(15):1577\u20131585","journal-title":"Circulation"},{"issue":"9038","key":"2_CR60","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","volume":"348","author":"T Lancet","year":"1996","unstructured":"Lancet T (1996) A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 348(9038):1329","journal-title":"Lancet"},{"issue":"21","key":"2_CR61","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1016\/j.jacc.2008.12.068","volume":"53","author":"CJ Lavie","year":"2009","unstructured":"Lavie CJ, Milani RV, Ventura HO (2009) Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol 53(21):1925\u20131932","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2_CR62","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1159\/000442706","volume":"134","author":"G Lemesle","year":"2016","unstructured":"Lemesle G et al (2016) Clopidogrel use as single antiplatelet therapy in outpatients with stable coronary artery disease: prevalence, correlates and association with prognosis (from the CORONOR Study). Cardiology 134(1):11\u201318","journal-title":"Cardiology"},{"issue":"3","key":"2_CR63","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.jjcc.2016.05.005","volume":"69","author":"G Lemesle","year":"2017","unstructured":"Lemesle G et al (2017) Angiotensin II receptor blockers versus angiotensin-converting enzyme inhibitors in patients with stable coronary artery disease: Prevalence, correlates, and prognostic impact (from the CORONOR study). J Cardiol 69(3):542\u2013547","journal-title":"J Cardiol"},{"key":"2_CR64","unstructured":"Li F, Li Y, Wang L (2013) The impact of anxiety and depression on prognosis in patients with coronary heart disease after percutaneous coronary intervention. China J Heal Psychol"},{"issue":"2","key":"2_CR65","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.ahj.2013.04.017","volume":"166","author":"EG Lima","year":"2013","unstructured":"Lima EG et al (2013) Impact of diabetes on 10-year outcomes of patients with multivessel coronary artery disease in the Medicine, Angioplasty, or Surgery Study II (MASS II) trial. Am Heart J 166(2):250\u2013257","journal-title":"Am Heart J"},{"issue":"9311","key":"2_CR66","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/S0140-6736(02)08090-X","volume":"359","author":"LH Lindholm","year":"2002","unstructured":"Lindholm LH et al (2002) Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 359(9311):1004\u20131010","journal-title":"Lancet"},{"key":"2_CR67","doi-asserted-by":"crossref","unstructured":"Lu Y, Hajifathalian K et al. (2014) Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1.8 million participants. Lancet 383(9921): 970\u2013983. Global burden of metabolic risk factors for chronic diseases C","DOI":"10.1016\/S0140-6736(13)61836-X"},{"key":"2_CR68","unstructured":"McGuire S, U.S. Department of Agriculture and U.S. Department of Health and Human Services, Dietary Guidelines for Americans (2010). 7th Edition, Washington, DC: U.S. Government Printing Office, January 2011. Adv Nutr 2(3): 293\u2013294 (2011)"},{"issue":"11","key":"2_CR69","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1046\/j.1360-0443.2001.961115472.x","volume":"96","author":"H Mcrobbie","year":"2001","unstructured":"Mcrobbie H, Hajek P (2001) Nicotine replacement therapy in patients with cardiovascular disease: guidelines for health professionals. Addiction 96(11):1547\u20131551","journal-title":"Addiction"},{"issue":"1","key":"2_CR70","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1586\/14779072.6.1.9","volume":"6","author":"C Melloni","year":"2008","unstructured":"Melloni C, Newby LK (2008) Metabolic efficiency with ranolazine for less ischemia in non-ST elevation acute coronary syndromes (MERLIN TIMI-36) study. Expert Rev Cardiovasc Ther 6(1):9\u201316","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"20","key":"2_CR71","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1093\/eurheartj\/ehs215","volume":"33","author":"ATF Members","year":"2012","unstructured":"Members ATF et al (2012) ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 33(20):2569\u20132619","journal-title":"Eur Heart J"},{"key":"2_CR72","unstructured":"Mohammad MA, Andell P, Koul S et al (2016) Cangrelor in combination with ticagrelor provides consistent and potent P2Y12-inhibition during and after primary percutaneous coronary intervention in real-world patients with ST-segment-elevation myocardial infarction. Platelets: 1\u20133"},{"issue":"6","key":"2_CR73","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.carrev.2016.04.004","volume":"17","author":"S Nagumo","year":"2016","unstructured":"Nagumo S, Wakabayashi K, Tsujiuchi M et al (2016) Clinical impact of undersized- versus oversized-stenting approaches in ST-elevation myocardial infarction. Cardiovasc Revascularization Med Incl Mol Interv 17(6):362\u2013368","journal-title":"Cardiovasc Revascularization Med Incl Mol Interv"},{"issue":"3","key":"2_CR74","doi-asserted-by":"publisher","first-page":"e0150475","DOI":"10.1371\/journal.pone.0150475","volume":"11","author":"Y Noh","year":"2016","unstructured":"Noh Y, Lee J, Shin S et al (2016) Antiplatelet therapy of cilostazol or sarpogrelate with aspirin and clopidogrel after percutaneous coronary intervention: a retrospective cohort study using the Korean National Health Insurance Claim Database. PLoS ONE 11(3):e0150475","journal-title":"PLoS ONE"},{"issue":"1","key":"2_CR75","first-page":"79","volume":"16","author":"L Oguzkurt","year":"2010","unstructured":"Oguzkurt L, Ozkan U, Gumus B, Coskun I, Koca N, Gulcan O (2010) Percutaneous aspiration thrombectomy in the treatment of lower extremity thromboembolic occlusions. Diagn Interv Radiol 16(1):79\u201383","journal-title":"Diagn Interv Radiol"},{"issue":"11","key":"2_CR76","doi-asserted-by":"publisher","first-page":"e0165672","DOI":"10.1371\/journal.pone.0165672","volume":"11","author":"H Peiyuan","year":"2016","unstructured":"Peiyuan H, Jingang Y, Haiyan X et al (2016) The comparison of the outcomes between primary PCI, fibrinolysis, and no reperfusion in patients\u2009>\/=\u200975 years old with ST-segment elevation myocardial infarction: results from the Chinese Acute Myocardial Infarction (CAMI) registry. PLoS ONE 11(11):e0165672","journal-title":"PLoS ONE"},{"key":"2_CR77","unstructured":"Pepine CJ et al (1994) Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST). Circulation 90(2): 762\u2013768"},{"key":"2_CR78","doi-asserted-by":"crossref","unstructured":"Pepine CJ et al (2003) A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial. JAMA J Am Med Assoc 13(2): 19\u201320","DOI":"10.1001\/jama.290.21.2805"},{"issue":"10","key":"2_CR79","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1161\/01.CIR.0000140983.69571.BA","volume":"110","author":"M Pfisterer","year":"2004","unstructured":"Pfisterer M (2004) Long-term outcome in elderly patients with chronic angina managed invasively versus by optimized medical therapy: four-year follow-up of the randomized Trial of Invasive versus Medical therapy in Elderly patients (TIME). Circulation 110(10):1213\u20131218","journal-title":"Circulation"},{"issue":"6","key":"2_CR80","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.ahj.2015.08.020","volume":"170","author":"F Prati","year":"2015","unstructured":"Prati F, Romagnoli E, Limbruno U et al (2015) Randomized evaluation of intralesion versus intracoronary abciximab and aspiration thrombectomy in patients with ST-elevation myocardial infarction: the COCTAIL II trial. Am Heart J 170(6):1116\u20131123","journal-title":"Am Heart J"},{"key":"2_CR81","unstructured":"Rehnqvist N et al (1995) Treatment of stable angina pectoris with calcium antagonists and beta-blockers. The APSIS study. Angina Prognosis Study in Stockholm. Cardiologia 40(40): 301"},{"issue":"2","key":"2_CR82","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1161\/CIRCULATIONAHA.109.869008","volume":"121","author":"NA Rigotti","year":"2010","unstructured":"Rigotti NA et al (2010) Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial. Circulation 121(2):221\u2013229","journal-title":"Circulation"},{"issue":"3","key":"2_CR83","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","volume":"37","author":"M Roffi","year":"2016","unstructured":"Roffi M, Patrono C, Collet JP et al (2016) 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 37(3):267\u2013315","journal-title":"Eur Heart J"},{"issue":"19","key":"2_CR84","first-page":"e435","volume":"131","author":"C Rosendorff","year":"2015","unstructured":"Rosendorff C et al (2015) Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension. Am J Med 131(19):e435","journal-title":"Am J Med"},{"key":"2_CR85","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s12872-015-0175-1","volume":"15","author":"JA Ross Terres","year":"2015","unstructured":"Ross Terres JA, Lozano-Ortega G, Kendall R, Sculpher MJ (2015) Cost-effectiveness of fondaparinux versus enoxaparin in non-ST-elevation acute coronary syndrome in Canada (OASIS-5). BMC Cardiovasc Disord 15:180","journal-title":"BMC Cardiovasc Disord"},{"issue":"10","key":"2_CR86","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1161\/CIRCULATIONAHA.107.743963","volume":"117","author":"LJ Shaw","year":"2008","unstructured":"Shaw LJ et al (2008) Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden results from the clinical outcomes utilizing revascularization and aggressive drug evaluation (COURAGE) trial nuclear substudy. Circulation 117(10):1283\u20131291","journal-title":"Circulation"},{"issue":"6","key":"2_CR87","doi-asserted-by":"publisher","first-page":"528","DOI":"10.14503\/THIJ-14-4891","volume":"42","author":"M Shehata","year":"2015","unstructured":"Shehata M, Fayez G, Nassar A (2015) Intensive Statin Therapy in NSTE-ACS patients undergoing PCI: clinical and biochemical effects. Tex Heart Inst J 42(6):528\u2013536","journal-title":"Tex Heart Inst J"},{"issue":"20","key":"2_CR88","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1016\/j.jacc.2007.03.007","volume":"49","author":"WA Shibeshi","year":"2007","unstructured":"Shibeshi WA, Young-Xu Y, Blatt CM (2007) Anxiety worsens prognosis in patients with coronary artery disease. J Am Coll Cardiol 49(20):2021","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"2_CR89","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1177\/1741826711409325","volume":"19","author":"DF Shu","year":"2012","unstructured":"Shu DF et al (2012) Long-term beta blockers for stable angina: systematic review and meta-analysis. Eur J Prev Cardiol 19(3):330\u2013341","journal-title":"Eur J Prev Cardiol"},{"key":"2_CR90","doi-asserted-by":"crossref","unstructured":"Squizzato A et al (2011) Clopidogrel plus Aspirin versus Aspirin alone for preventing cardiovascular disease. Cochrane Database Syst Rev (1): CD005158","DOI":"10.1002\/14651858.CD005158.pub3"},{"issue":"9909","key":"2_CR91","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1016\/S0140-6736(13)61615-3","volume":"382","author":"PG Steg","year":"2013","unstructured":"Steg PG, Bhatt DL, Hamm CW et al (2013) Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: a pooled analysis of patient-level data. Lancet 382(9909):1981\u20131992","journal-title":"Lancet"},{"issue":"3","key":"2_CR92","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.jacc.2006.05.044","volume":"48","author":"PH Stone","year":"2006","unstructured":"Stone PH et al (2006) Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial. J Am Coll Cardiol 48(3):566\u2013575","journal-title":"J Am Coll Cardiol"},{"key":"2_CR93","unstructured":"Szwed H et al (2001) Combination treatment in stable effort angina using trimetazidine and metoprolol. Results of a randomized, double-blind, multicentre study (TRIMPOL II). 22(24): 2267\u20132274"},{"issue":"5","key":"2_CR94","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.amjcard.2014.12.015","volume":"115","author":"G Tang","year":"2015","unstructured":"Tang G, Wang D, Long J, Yang F, Si L (2015) Meta-analysis of the association between whole grain intake and coronary heart disease risk. Am J Cardiol 115(5):625\u2013629","journal-title":"Am J Cardiol"},{"key":"2_CR95","unstructured":"Task Force on the management of STseamiotESoC, Steg PG, James SK et al (2012) ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 33(20): 2569\u20132619"},{"issue":"9667","key":"2_CR96","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/S0140-6736(09)60319-6","volume":"373","author":"TA Trikalinos","year":"2009","unstructured":"Trikalinos TA et al (2009) Percutaneous coronary interventions for non-acute coronary artery disease: a quantitative 20-year synopsis and a network meta-analysis. Lancet 373(9667):911","journal-title":"Lancet"},{"issue":"16","key":"2_CR97","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1001\/jama.2013.279206","volume":"310","author":"JA Udell","year":"2013","unstructured":"Udell JA et al (2013) Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis. JAMA 310(16):1711","journal-title":"JAMA"},{"issue":"2","key":"2_CR98","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.ijcard.2012.11.001","volume":"168","author":"C Vitale","year":"2012","unstructured":"Vitale C et al (2012) Efficacy of trimetazidine on functional capacity in symptomatic patients with stable exertional angina\u2013the VASCO-angina study. Int J Cardiol 168(2):1078\u20131081","journal-title":"Int J Cardiol"},{"key":"2_CR99","unstructured":"Von AT (1995) Medical treatment to reduce total ischemic burden: total ischemic burden bisoprolol study (TIBBS), A multicenter trial comparing bisoprolol and nifedipine. The TIBBS investigators. J Am Coll Cardiol 25(1): 231\u2013238"},{"issue":"20","key":"2_CR100","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1001\/jama.2008.711","volume":"300","author":"MA Whooley","year":"2011","unstructured":"Whooley MA et al (2011) Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA J Am Med Assoc 300(20):2379\u20132388","journal-title":"JAMA J Am Med Assoc"},{"issue":"51\u201352","key":"2_CR101","first-page":"2653","volume":"138","author":"N Worm","year":"2013","unstructured":"Worm N, Belz GG, Stein-Hammer C (2013) Moderate wine consumption and prevention of coronary heart disease. Dtsch Med Wochenschr 138(51\u201352):2653\u20132657","journal-title":"Dtsch Med Wochenschr"},{"key":"2_CR102","doi-asserted-by":"crossref","unstructured":"Yusuf S et al (2000) Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 342(3): 145\u2013153. The Heart Outcomes Prevention Evaluation Study Investigators","DOI":"10.1056\/NEJM200001203420301"},{"issue":"15","key":"2_CR103","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1056\/NEJMoa0801317","volume":"358","author":"S Yusuf","year":"2008","unstructured":"Yusuf S et al (2008) Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 358(15):1547\u20131559","journal-title":"N Engl J Med"},{"key":"2_CR104","doi-asserted-by":"crossref","unstructured":"Zhao XM, Gao CY, Chu YJ et al (2015) Fondaparinux vs. enoxaparin in patients with non-ST elevation acute coronary syndromes (NSTE-ACS) treated with percutaneous coronary intervention and tirofiban: an exploratory study in China. J Clin Pharm Ther","DOI":"10.1111\/jcpt.12315"},{"issue":"24","key":"2_CR105","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1161\/CIRCULATIONAHA.115.021101","volume":"133","author":"G Zong","year":"2016","unstructured":"Zong G, Gao A, Hu FB, Sun Q (2016) Whole grain intake and mortality from all causes, cardiovascular disease, and cancer: a meta-analysis of prospective cohort studies. Circulation 133(24):2370\u20132380","journal-title":"Circulation"}],"container-title":["Advances in Experimental Medicine and Biology","Coronary Artery Disease: Therapeutics and Drug Discovery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-15-2517-9_2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T13:24:10Z","timestamp":1585920250000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-981-15-2517-9_2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9789811525162","9789811525179"],"references-count":105,"URL":"https:\/\/doi.org\/10.1007\/978-981-15-2517-9_2","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"26 March 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}